Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients

Respirology

Volumn 14, Issue 4, 2009, Pages 486-494

  Crothers, Kristina ^a,c   Huang, Laurence ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AIDS; Antiretroviral therapy; Highly active; HIV; Immune reconstitution inflammatory syndrome; Lung disease

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASPERGILLUS FUMIGATUS; AUTOIMMUNE DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CRYPTOCOCCUS NEOFORMANS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; INCIDENCE; LUNG COMPLICATION; MALIGNANT NEOPLASTIC DISEASE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SARCOIDOSIS; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LUNG DISEASES, FUNGAL; TUBERCULOSIS, PULMONARY;

EID: 65649151953     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01468.x     Document Type: Review

References (64)

1. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 2002 21 : 803 9. (Pubitemid 35435702)
2. Manandhar R, Shrestha N, Butlin CR, Roche PW. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy. Clin. Exp. Immunol. 2002 128 : 333 8. (Pubitemid 34534049)
3. Cheng VC, Yuen KY, Wong SS, Woo PC, Ho PL et al. Immunorestitution diseases in patients not infected with HIV. Eur. J. Clin. Microbiol. Infect. Dis. 2001 20 : 402 6. (Pubitemid 32646362)
4. Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES et al. Immunorestitution disease involving the innate and adaptive response. Clin. Infect. Dis. 2000 30 : 882 92. (Pubitemid 32250325)
5. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect. Dis. 2007 7 : 395 401. (Pubitemid 46765196)
6. French MA, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992 6 : 1293 7.
7. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann. Intern. Med. 2000 133 : 447 54.
8. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004 18 : 1615 27. (Pubitemid 39095778)
9. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008 22 : 601 10.
10. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000 1 : 107 15.
11. Jevtovic DJ, Salemovic D, Ranin J, Pesic I, Zerjav S et al. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2005 6 : 140 3. (Pubitemid 40425979)
12. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005 19 : 399 406. (Pubitemid 40446186)
13. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J. Antimicrob. Chemother. 2006 57 : 167 70. (Pubitemid 43160154)
14. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin. Infect. Dis. 2006 42 : 418 27. (Pubitemid 43122323)
15. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect. Dis. 2005 5 : 361 73. (Pubitemid 40779257)
16. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007 21 : 335 41. (Pubitemid 46175045)
17. Shelburne SA 3rd., Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002 81 : 213 27. (Pubitemid 34507208)
18. Ferrand RA, Elgalib A, Newsholme W, Childerhouse A, Edwards SG et al. Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis. Int. J. STD AIDS 2006 17 : 349 50. (Pubitemid 43668177)
19. Lawn SD, Macallan DC. Hypercalcemia: a manifestation of immune reconstitution complicating tuberculosis in an HIV-infected person. Clin. Infect. Dis. 2004 38 : 154 5. (Pubitemid 38045889)
20. Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998 351 : 252 5. (Pubitemid 28043950)
21. Salama C, Policar M, Venkataraman M. Isolated pulmonary Mycobacterium avium complex infection in patients with human immunodeficiency virus infection: case reports and literature review. Clin. Infect. Dis. 2003 37. e35 40.
22. Phillips P, Bonner S, Gataric N, Bai T, Wilcox P et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin. Infect. Dis. 2005 41 : 1483 97. (Pubitemid 41579994)
23. Shelburne SA 3rd., Darcourt J, White AC Jr., Greenberg SB, Hamill RJ et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 2005 40 : 1049 52. (Pubitemid 40418316)
24. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005 19 : 1043 9. (Pubitemid 40961144)
25. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin. Infect. Dis. 2002 35 : e128 33.
26. Trevenzoli M, Cattelan AM, Rea F, Sasset L, Semisa M et al. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J. Infect. 2002 45 : 173 9. (Pubitemid 36104841)
27. Barry SM, Lipman MC, Deery AR, Johnson MA, Janossy G. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med. 2002 3 : 207 11.
28. Wislez M, Bergot E, Antoine M, Parrot A, Carette MF et al. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 2001 164 : 847 51. (Pubitemid 32881923)
29. Koval CE, Gigliotti F, Nevins D, Demeter LM. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin. Infect. Dis. 2002 35 : 491 3.
30. Shelburne SA 3rd., Visnegarwala F, Adams C, Krause KL, Hamill RJ et al. Unusual manifestations of disseminated histoplasmosis in patients responding to antiretroviral therapy. Am. J. Med. 2005 118 : 1038 41. (Pubitemid 41297770)
31. Sambatakou H, Denning DW. Invasive pulmonary aspergillosis transformed into fatal mucous impaction by immune reconstitution in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 2005 24 : 628 33. (Pubitemid 41456146)
32. Gomez V, Smith PR, Burack J, Daley R, Rosa U. Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 2000 31 : 1278 80. (Pubitemid 32295462)
33. Haramati LB, Lee G, Singh A, Molina PL, White CS. Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology 2001 218 : 242 6. (Pubitemid 32151302)
34. Morris DG, Jasmer RM, Huang L, Gotway MB, Nishimura S et al. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest 2003 124 : 929 35. (Pubitemid 37123311)
35. Foulon G, Wislez M, Naccache JM, Blanc FX, Rabbat A et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 2004 38 : 418 25. (Pubitemid 38200122)
36. Trevenzoli M, Cattelan AM, Marino F, Marchioro U, Cadrobbi P. Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad. Med. J. 2003 79 : 535 8. (Pubitemid 37193893)
37. Almeida FA Jr., Eiger JS, Sager G. Coexistent sarcoidosis and HIV infection: an immunological paradox? J. Infect. 2006 52 : 195 201. (Pubitemid 43286186)
38. Ferrand RA, Cartledge JD, Connolly J, Standish RA, Miller RF. Immune reconstitution sarcoidosis presenting with hypercalcaemia and renal failure in HIV infection. Int. J. STD AIDS 2007 18 : 138 9. (Pubitemid 46310283)
39. Naccache JM, Antoine M, Wislez M, Fleury-Feith J, Oksenhendler E et al. Sarcoidosis-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am. J. Respir. Crit. Care Med. 1999 159 : 2009 13. (Pubitemid 29275077)
40. Ingiliz P, Appenrodt B, Gruenhage F, Vogel M, Tschampa H et al. Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation. HIV Med. 2006 7 : 411 4. (Pubitemid 44123253)
41. Powles T, Thirlwell C, Nelson M, Bower M. Immune reconstitution inflammatory syndrome mimicking relapse of AIDS related lymphoma in patients with HIV 1 infection. Leuk. Lymphoma. 2003 44 : 1417 9. (Pubitemid 36764299)
42. Collazos J, Ojanguren J, Mayo J, Martinez E, Ibarra S. Lymphoma developing shortly after the onset of highly active antiretroviral therapy in HIV-infected patients. AIDS 2002 16 : 1304 6. (Pubitemid 34666673)
43. Feller L, Lemmer J. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect. Agent Cancer 2008 3 : 1.
44. Connick E, Kane MA, White IE, Ryder J, Campbell TB. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin. Infect. Dis. 2004 39 : 1852 5. (Pubitemid 39657269)
45. Godoy MC, Rouse H, Brown JA, Phillips P, Forrest DM et al. Imaging features of pulmonary Kaposi sarcoma-associated immune reconstitution syndrome. AJR Am. J. Roentgenol. 2007 189 : 956 65. (Pubitemid 47479782)
46. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J. Acquir. Immune. Defic. Syndr. 2007 46 : 456 62. (Pubitemid 350098697)
47. Price P, Morahan G, Huang D, Stone E, Cheong KY et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002 16 : 2043 7. (Pubitemid 35205268)
48. Price P, Mathiot N, Krueger R, Stone S, Keane NM et al. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J. Clin. Virol. 2001 22 : 279 87. (Pubitemid 32846559)
49. Stone SF, Price P, French MA. Immune restoration disease: a consequence of dysregulated immune responses after HAART. Curr. HIV Res. 2004 2 : 235 42. (Pubitemid 38854936)
50. Cianchetta-Sivori M, Raso S, Fernandez-Guerrero M, Gorgolas M, Garcia R. Do CD8(+)CD25(+) cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART? AIDS 2007 21 : 2347 9. (Pubitemid 350287464)
51. Battegay M, Nuesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect. Dis. 2006 6 : 280 7.
52. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006 20 : F1 7.
53. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 1999 13 : 177 84. (Pubitemid 29050405)
54. Martinez E, Gatell J, Moran Y, Aznar E, Buira E et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin. Infect. Dis. 1998 27 : 1510 3. (Pubitemid 29242429)
55. Lawn SD, Wilkinson RJ, Lipman MC, Wood R. Immune reconstitution and 'unmasking' of tuberculosis during antiretroviral therapy. Am. J. Respir. Crit. Care Med. 2008 177 : 680 5.
56. Adult Prevention and Treatment of Opportunistic Infections Guidelines Working Group. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents {DRAFT}. 18 June 2008; pp 1-289. {10 Accessed August 2008.} Available from URL: http://aidsinfo.nih.gov/ contentfiles/Adult-OI.pdf
57. Lipman MC, Carding SK. Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis? AIDS 2007 21 : 383 4. (Pubitemid 46175057)
58. Hardwick C, White D, Morris E, Monteiro EF, Breen RA et al. Montelukast in the treatment of HIV associated immune reconstitution disease. Sex. Transm. Infect. 2006 82 : 513 4. (Pubitemid 46025198)
59. Huang L, Quartin A, Jones D, Havlir DV. Intensive care of patients with HIV infection. N. Engl. J. Med. 2006 355 : 173 81. (Pubitemid 44050399)
60. Zolopa A, Andersen J, Komarow L, Sanchez A, Suckow C et al. Immediate vs deferred ART in the setting of acute AIDS-related opportunistic infection: final results of a randomized strategy trial, ACTG A5164. Proceedings of the 15th CROI; 2008, Boston, MA. Abstract 142.
61. Morris A, Wachter RM, Luce J, Turner J, Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003 17 : 73 80. (Pubitemid 36106300)
62. Schiffer JT, Sterling TR. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J. Acquir. Immune. Defic. Syndr. 2007 44 : 229 34. (Pubitemid 46292227)
63. Easterbrook PJ. HIV immune reconstitution syndrome in sub-Saharan Africa. AIDS 2008 22 : 643 5.
64. Park WB, Choe PG, Jo JH, Kim SH, Bang JH et al. Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long-term clinical outcome. AIDS 2006 20 : 2390 2.